Advertisement

Local Surgical Treatment of Hepatic Metastases from Colorectal Carcinoma: Survival Times and Sites of Recurrence

  • Nicholas J. Petrelli
  • Lemuel Herrera
  • Arnold Mittelman
Part of the Developments in Oncology book series (DION, volume 42)

Summary

This chapter summarizes the experience at Roswell Park Memorial Institute with resectable liver metastases and with hepatic artery ligation for unresectable metastases from colorectal carcinoma. Survival times and patterns of recurrence were noted in 36 patients with documented colorectal adenocarcinoma metastatic to the liver who underwent resection. The overall median survival time following liver resection was 22 months. Survival was not influenced by the type of surgical resection performed. Survival time following resection of solitary lesions was 28 months and following resection of multiple lesions, 21 months. The difference between survival times of patients with synchronous metastases (25 months) and patients with metachronous metastases (16 months) from the time of liver resection was not statistically significant. Patterns of recurrence revealed that 11 of 17 patients experienced recurrences in the liver and in extrahepatic sites. Only two patients died with recurrent metastasis only in the liver.

From April 1975 to January 1982, 97 patients underwent hepatic artery ligation for biopsyroven metastatic adenocarcinoma of the colon and rectum. All patients undergoing ligation had 50% or more of their liver involved with metastases. The overall median survival time was 10 months. The survival rate was determined in relation to performance status, preoperative alkaline phosphatase and total bilirubin levels, and the presence of extrahepatic intra abdominal disease. We cannot conclude that hepatic artery ligation is an effective means of treating unresectable liver metastases from this retrospective study. What can be concluded is that important patient stratifications in predicting survival time must be taken into consideration for evaluating any form of treatment for unresectable liver metastases. The median survival time for patients with 0–1 performance status was 12 months. Patients with preoperative alkaline phosphatase levels less than two times normal also had a median survival time of 12 months. For patients with total bilirubin levels of less than two times normal the median survival time was four months.

Keywords

Liver Metastasis Liver Resection Hepatic Resection Median Survival Time Hepatic Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Silverberg E: Cancer Statistics, 1985. CA 35: 19–35, 1985.Google Scholar
  2. 2.
    Wanebo J, Semoglou C, Attiyeh F, Stearns M: Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 135: 81–85, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Foster JH, Berman MM: Solid liver tumors. WB Saunders, Philadelphia, 1977.Google Scholar
  4. 4.
    Logan SE, Meier SJ, Ramming KP: Hepatic resection of metastatic colorectal carcinoma. Arch Surg 117: 25–28, 1982.PubMedGoogle Scholar
  5. 5.
    Petrelli NJ, Barcewicz PA, Evans JT, Ledesma EJ, Lawrence DD, Mittelman A: Hepatic artery ligation for liver metastasis in colorectal carcinoma. Cancer 53: 1347–1353, 1984.PubMedCrossRefGoogle Scholar
  6. 6.
    Larmi TKI, Karkola P, Klintrup H, Heikkinen E: Treatment of patients with hepatic tumors and jaundice by ligation of the hepatic artery. Arch Surg 108: 178–183, 1974.PubMedGoogle Scholar
  7. 7.
    Fortner JG, Mulcare RJ, Solis A, Watson RC, Golbey RB: Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy, Ann Surg 178: 162–172, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Sparks FC, Mosher MB, Wolfgang G, Hallaver WC, Silverstein M3, Rangel D, Passaro E Jr, Morton DL: Hepatic artery ligation and postoperative chemotherapy for hepatic metastases: Clinical and pathologic results. Cancer 35: 1074–1082, 1975.Google Scholar
  9. 9.
    Gulesserian HP, Lawton RL, Condon RE: Hepatic artery ligation and cytotoxic infusion in treatment of liver metastasis. Arch Surg 105: 280–295, 1972.PubMedGoogle Scholar
  10. 10.
    Cady B, Oberfield RA: Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 127: 220–227, 1974.PubMedCrossRefGoogle Scholar
  11. 11.
    Ramming KP, Sparks FC, Eilber FR, Holmes EC, Morton DL: Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 132: 236–242, 1976.PubMedCrossRefGoogle Scholar
  12. 12.
    Grage TB, Vassilopoules PP, Shingleton WW, Jubert AV, Elias EG, Aust JB, Moss SE: Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group Study. Surgery 86: 550–555, 1979.PubMedGoogle Scholar
  13. 13.
    Lise M, Cagol PP, Nitti I, Feltrin G, Fosser V, Cecchetto A, Rubaltelli L, Pucciarelli S: Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. Int Surg 65: 315–323, 1980.PubMedGoogle Scholar
  14. 14.
    Dahl EP, Fredlung PE, Tylen U, Bengmark S: Transient hepatic dearterialization followed by regional intraarterial 5-fluorouracil infusion as treatment for liver tumors. Ann Surg 193: 82–88, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Grage TB, Shingleton WW, Jubert AV, Elias EG, Aust JB, Moss SE: Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Front Gastrointest Res 5: 116–129, 1979.PubMedGoogle Scholar
  16. 16.
    Balch CM, Urist MM, Soong SJ, McGregor M: A prospective phase II clinical trial of continuous FUdR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198: 567–573, 1983.PubMedCrossRefGoogle Scholar
  17. 17.
    Kemeny N, Daly JM, Oderman P, Schike M: Hepatic infusion chemotherapy for metastatic colorectal carcinoma, results and complications (Abstract). Proc Am Soc Clin Oncol 2: 123, 1983.Google Scholar
  18. 18.
    Weiss GR, Garnick MB, Osteen RT, Steele GD Jr, Wilson RE, Shade D, Kaplan W, Boxt L, Kandarpa K, Mayer R, Frei ET III: Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. 3 Clin Oncol 1: 337–344, 1983.Google Scholar
  19. 19.
    Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E: Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53: 1336-1343,Google Scholar
  20. 20.
    Taylor I: Cytotoxic perfusion for colorectal liver metastases. Br J Surg 65: 109–114, 1978.PubMedCrossRefGoogle Scholar
  21. 21.
    Douglass HO Jr, Lavin PT, Woll J, Conroy JF, Carbone P: Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2’-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)- l(2-chloroethyl)-l-nitrosourea. A phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Cancer 42: 2538–2545, 1978.PubMedCrossRefGoogle Scholar
  22. 22.
    Petrelli NJ, Mittelman A: An analysis of chemotherapy for colorectal carcinoma. J Surg Oncol 25: 201–206, 1984.PubMedCrossRefGoogle Scholar
  23. 23.
    Borgelt BB, Gelber R, Brady LW, Griffin T, Hendrickson FR: The palliation of hepatic metastases: Results of the Radiation Therapy Oncology Group Pilot Study. Int J Radiat Oncol Biol Phys 7: 387–391, 1981.Google Scholar
  24. 24.
    Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S: Intraarterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 30: 830–862, 1982.Google Scholar
  25. 25.
    Logan S, Meier S, Ramming K, Morton D, Longmire W: Hepatic resection of metastatic colorectal carcinoma. Arch Surg 117: 23–28, 1982.Google Scholar
  26. 26.
    Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM: Resection of hepatic metastases from colorectal cancer. Arch Surg 119: 647–651, 1984.PubMedGoogle Scholar
  27. 27.
    Iwatsuki S, Shaw BW, Starzl TE: Experience with 130 liver resections. Ann Surg 197: 247–233, 1983.PubMedCrossRefGoogle Scholar
  28. 28.
    Flanagan K Jr, Foster JH: Hepatic resection for metastatic cancer. Am J Surg 113: 331–337, 1967.Google Scholar
  29. 29.
    Cady B, Monson DO, Swinton NW: Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131: 697–700, 1970.PubMedGoogle Scholar
  30. 30.
    Bengmark S, Hafstrom L: The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23: 198–202, 1969.PubMedCrossRefGoogle Scholar
  31. 31.
    Jaffe BM, Donegan WL, Watson F, Spratt J: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127: 1–11, 1968.PubMedGoogle Scholar
  32. 32.
    Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Amer Stat Assoc 33: 437–481, 1938.CrossRefGoogle Scholar
  33. 33.
    Engelman L, Frame JW, Jennrick RI: BMDP Biomedical Computer Programs, P- series. In: Dixon WJ, Brown MB (eds). Publications in Automatic Computation. University of California Press, Los Angeles 1979, pp 880.Google Scholar
  34. 34.
    Wilson SM, Adson MA: Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111: 330–334, 1976.PubMedGoogle Scholar
  35. 35.
    Foster J: Survival after liver resection for secondary tumors. Am J Surg 133: 389–394, 1978.CrossRefGoogle Scholar
  36. 36.
    Adson M, van Heerden J: Major hepatic resections for metastatic colorectal cancer. Ann Surg 191: 376–383, 1980.CrossRefGoogle Scholar
  37. 37.
    Starzl TE, Koep LJ, Weil R, Lilly JR, Putnam CW, Aldreter JA: Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet 130: 208–213, 1980.Google Scholar
  38. 38.
    Steele G, Osteen RT, Wilson RE, Brooks DC, Mayer RJ, Zamcheck N, Ravikumar TS: Patterns of failure after surgical cure of large liver tumors: A change in the proxinnate cause of death and a need for effective systemic adjuvant therapy. Am J Surg W: 554–559, 1984.Google Scholar
  39. 39.
    Goslin R, Steele G, Zamcheck N, Mayer R, Maclntyre J: Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25: 749–754, 1982.PubMedCrossRefGoogle Scholar
  40. 40.
    Petrelli NJ, Bonnheim DC, Herrera LO, Mittelman A: A proposed classification system for liver metastasis from colorectal carcinoma. Dis Colon Rectum 27: 249–232, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • Nicholas J. Petrelli
  • Lemuel Herrera
  • Arnold Mittelman

There are no affiliations available

Personalised recommendations